Literature DB >> 2564273

Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain.

G DuVal1, B A Fowler.   

Abstract

Carrier-free 203Pb has been used to label high affinity lead-binding proteins in rat brain cytosol to allow their initial characterization. The low molecular weight 203Pb-protein complex collected from a Sephadex G-75 column eluate has been further purified by Sephadex DEAE chromatography and then partially characterized. The protein has a molecular weight of 23,000 daltons as determined by SDS polyacrylamide gel electrophoresis and significant levels of glutamic acid (9.3%), aspartic acid (10.8%) and cysteine (9.4%). Western blot studies conducted using the polyclonal antibody to the renal lead-binding proteins showed a lack of reactivity, indicating that the brain protein is immunologically distinct from that found in the kidney.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564273     DOI: 10.1016/0006-291x(89)92420-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Purification and characterization of a low molecular weight zinc binding protein from human placenta.

Authors:  S Honey; G I Dhall; R Nath
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

2.  Lead-binding proteins: a review.

Authors:  Harvey C Gonick
Journal:  J Toxicol       Date:  2011-09-19

3.  Effects of lead on the kidney: roles of high-affinity lead-binding proteins.

Authors:  B A Fowler; G DuVal
Journal:  Environ Health Perspect       Date:  1991-02       Impact factor: 9.031

Review 4.  Roles of lead-binding proteins in mediating lead bioavailability.

Authors:  B A Fowler
Journal:  Environ Health Perspect       Date:  1998-12       Impact factor: 9.031

Review 5.  Chronic Kidney Disease and Exposure to Nephrotoxic Metals.

Authors:  Sarah E Orr; Christy C Bridges
Journal:  Int J Mol Sci       Date:  2017-05-12       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.